CT-guided percutaneous cyanoacrylate injection targeting the spinal cerebrospinal fluid leak: a potential therapeutic option for spontaneous intracranial hypotension.

Intervention Intracranial Pressure Liquid Embolic Material Spine Technique

Journal

Journal of neurointerventional surgery
ISSN: 1759-8486
Titre abrégé: J Neurointerv Surg
Pays: England
ID NLM: 101517079

Informations de publication

Date de publication:
16 Mar 2023
Historique:
received: 14 12 2022
accepted: 06 03 2023
entrez: 17 3 2023
pubmed: 18 3 2023
medline: 18 3 2023
Statut: aheadofprint

Résumé

We report the first case series of spontaneous intracranial hypotension (SIH) patients who underwent CT-guided percutaneous cyanoacrylate injection targeting the cerebrospinal fluid (CSF) leak. A retrospective analysis was performed for all consecutive cases of SIH patients with CSF leak confirmed on CT myelography, treated by CT-guided percutaneous cyanoacrylate injection at our institution from 2016 to 2022. On pretreatment brain and spine MRIs, we analyzed signs of SIH according to the Bern score, and dichotomized cases into positive/negative for spinal longitudinal extradural CSF collection (SLEC-P or SLEC-N). The leaks detected on CT myelography were classified into three types according to Schievink 11 patients were included (mean age 48.4 years, six men). Five SLEC-P type 1, three SLEC-P type 2, and three SLEC-N type 3 leaks were identified. All patients had significant signs of SIH on pretreatment brain MRI (mean Bern score 7.8±1.1). Six patients underwent a foraminal puncture, and five patients had a cervical epidural approach. Two patients experienced mild and transient locoregional pain after cervical epidural injection. Mean HIT-6 score at baseline was 66.8±3.2 and at the 6-month follow-up was 38±3.6 (P<0.001). All patients achieved improvement in their symptoms, with 82% of them (9/11) having complete resolution of headaches and SIH findings on CT scans at 6 months. No clinical worsening or recurrence was observed. CT-guided percutaneous cyanoacrylate injection may be a potential therapeutic option for the different types of CSF leak causing SIH.

Sections du résumé

BACKGROUND BACKGROUND
We report the first case series of spontaneous intracranial hypotension (SIH) patients who underwent CT-guided percutaneous cyanoacrylate injection targeting the cerebrospinal fluid (CSF) leak.
METHODS METHODS
A retrospective analysis was performed for all consecutive cases of SIH patients with CSF leak confirmed on CT myelography, treated by CT-guided percutaneous cyanoacrylate injection at our institution from 2016 to 2022. On pretreatment brain and spine MRIs, we analyzed signs of SIH according to the Bern score, and dichotomized cases into positive/negative for spinal longitudinal extradural CSF collection (SLEC-P or SLEC-N). The leaks detected on CT myelography were classified into three types according to Schievink
RESULTS RESULTS
11 patients were included (mean age 48.4 years, six men). Five SLEC-P type 1, three SLEC-P type 2, and three SLEC-N type 3 leaks were identified. All patients had significant signs of SIH on pretreatment brain MRI (mean Bern score 7.8±1.1). Six patients underwent a foraminal puncture, and five patients had a cervical epidural approach. Two patients experienced mild and transient locoregional pain after cervical epidural injection. Mean HIT-6 score at baseline was 66.8±3.2 and at the 6-month follow-up was 38±3.6 (P<0.001). All patients achieved improvement in their symptoms, with 82% of them (9/11) having complete resolution of headaches and SIH findings on CT scans at 6 months. No clinical worsening or recurrence was observed.
CONCLUSIONS CONCLUSIONS
CT-guided percutaneous cyanoacrylate injection may be a potential therapeutic option for the different types of CSF leak causing SIH.

Identifiants

pubmed: 36927657
pii: jnis-2022-020004
doi: 10.1136/jnis-2022-020004
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Liang Liao (L)

Department of Diagnostic and Interventional Neuroradiology, CHRU de Nancy, Nancy, Lorraine, France l.liao@chru-nancy.fr.
LORIA, Vandoeuvre-les-Nancy, Grand Est, France.

Romain Tonnelet (R)

Department of Diagnostic and Interventional Neuroradiology, CHRU de Nancy, Nancy, Lorraine, France.
University of Lorraine, Nancy, Grand Est, France.

Emmanuelle Schmitt (E)

Department of Diagnostic and Interventional Neuroradiology, CHRU de Nancy, Nancy, Lorraine, France.

Sophie Planel (S)

Department of Diagnostic and Interventional Neuroradiology, CHRU de Nancy, Nancy, Lorraine, France.

François Zhu (F)

Department of Diagnostic and Interventional Neuroradiology, CHRU de Nancy, Nancy, Lorraine, France.
University of Lorraine, Nancy, Grand Est, France.

Patricio Muszynski (P)

Department of Diagnostic and Interventional Neuroradiology, CHRU de Nancy, Nancy, Lorraine, France.
Instituto Oulton, Cordoba, Argentina.

Oana Harsan (O)

Department of Diagnostic and Interventional Neuroradiology, CHRU de Nancy, Nancy, Lorraine, France.
University of Lorraine, Nancy, Grand Est, France.

René Anxionnat (R)

Department of Diagnostic and Interventional Neuroradiology, CHRU de Nancy, Nancy, Lorraine, France.
University of Lorraine, Nancy, Grand Est, France.

Serge Bracard (S)

Department of Diagnostic and Interventional Neuroradiology, CHRU de Nancy, Nancy, Lorraine, France.
University of Lorraine, Nancy, Grand Est, France.

Marc Braun (M)

Department of Diagnostic and Interventional Neuroradiology, CHRU de Nancy, Nancy, Lorraine, France.
University of Lorraine, Nancy, Grand Est, France.

Classifications MeSH